Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2007 1
2008 1
2009 1
2010 2
2013 1
2014 2
2020 2
2021 2
2022 2
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Reply to S. A. Narod et al.
Azim HA Jr, Ameye L, Paesmans M, Lambertini M. Azim HA Jr, et al. J Clin Oncol. 2020 Dec 20;38(36):4352-4354. doi: 10.1200/JCO.20.02850. Epub 2020 Oct 30. J Clin Oncol. 2020. PMID: 33125310 No abstract available.
Re: increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy: R. K. Nam, R. Saskin, Y. Lee, Y. Liu, C. Law, L. H. Klotz, D. A. Loblaw, J. Trachtenberg, A. Stanimirovic, A. E. Simor, A. Seth, D. R. Urbach and S. A. Narod J Urol 2010; 183: 963-969.
Neulander EZ, Yusim I, Kaneti J. Neulander EZ, et al. J Urol. 2010 Nov;184(5):2216-7; author reply 2217. doi: 10.1016/j.juro.2010.06.121. Epub 2010 Sep 22. J Urol. 2010. PMID: 20864132 No abstract available.
Frequency of premature menopause in women who carry a BRCA1 or BRCA2 mutation.
Finch A, Valentini A, Greenblatt E, Lynch HT, Ghadirian P, Armel S, Neuhausen SL, Kim-Sing C, Tung N, Karlan B, Foulkes WD, Sun P, Narod S; Hereditary Breast Cancer Study Group. Finch A, et al. Fertil Steril. 2013 May;99(6):1724-8. doi: 10.1016/j.fertnstert.2013.01.109. Epub 2013 Feb 13. Fertil Steril. 2013. PMID: 23414920 Free article.
SETTING: Patients in an academic research environment. PATIENT(S): Women who carry a BRCA1 or BRCA2 mutation (case subjects) and women who do not carry a mutation (control subjects). INTERVENTION(S): Survey about reproductive history administered on study entry and …
SETTING: Patients in an academic research environment. PATIENT(S): Women who carry a BRCA1 or BRCA2 mutation (case subjects) and wome …
Fertility in women with BRCA mutations: a case-control study.
Pal T, Keefe D, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group. Pal T, et al. Fertil Steril. 2010 Apr;93(6):1805-8. doi: 10.1016/j.fertnstert.2008.12.052. Epub 2009 Feb 6. Fertil Steril. 2010. PMID: 19200971 Free article.
INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): History of fertility problems (yes/no) and prior use of fertility medications (yes/no) in cases and controls, obtained through administered questionnaire. RESULT(S): There was no difference in mean parity betwee …
INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): History of fertility problems (yes/no) and prior use of fertility medications …
A prior diagnosis of breast cancer is a risk factor for breast cancer in BRCA1 and BRCA2 carriers.
Narod SA, Tung N, Lubinski J, Huzarski T, Robson M, Lynch HT, Neuhausen SL, Ghadirian P, Kim-Sing C, Sun P, Foulkes WD; Hereditary Breast Cancer Clinical Study Group. Narod SA, et al. Curr Oncol. 2014 Apr;21(2):64-8. doi: 10.3747/co.21.1656. Curr Oncol. 2014. PMID: 24764694 Free PMC article.
BACKGROUND: The risk of breast cancer in carriers of BRCA1 and BRCA2 mutations is influenced by factors other than the genetic mutation itself. Modifying factors include a woman's reproductive history and family history of cancer. Risk factors are more likely to be present …
BACKGROUND: The risk of breast cancer in carriers of BRCA1 and BRCA2 mutations is influenced by factors other than the genetic mutation itse …
Risk of Second Primary Thyroid Cancer in Women with Breast Cancer.
Cieszyńska M, Kluźniak W, Wokołorczyk D, Cybulski C, Huzarski T, Gronwald J, Falco M, Dębniak T, Jakubowska A, Derkacz R, Marciniak W, Lener M, Woronko K, Mocarz D, Baszuk P, Bryśkiewicz M, Narod SA, Lubiński J. Cieszyńska M, et al. Cancers (Basel). 2022 Feb 15;14(4):957. doi: 10.3390/cancers14040957. Cancers (Basel). 2022. PMID: 35205705 Free PMC article.
Serum Selenium Level Predicts 10-Year Survival after Breast Cancer.
Szwiec M, Marciniak W, Derkacz R, Huzarski T, Gronwald J, Cybulski C, Dębniak T, Jakubowska A, Lener M, Falco M, Kładny J, Baszuk P, Duszyński J, Kotsopoulos J, Narod SA, Lubiński J. Szwiec M, et al. Nutrients. 2021 Mar 16;13(3):953. doi: 10.3390/nu13030953. Nutrients. 2021. PMID: 33809461 Free PMC article.
Analysis of PALB2/FANCN-associated breast cancer families.
Tischkowitz M, Xia B, Sabbaghian N, Reis-Filho JS, Hamel N, Li G, van Beers EH, Li L, Khalil T, Quenneville LA, Omeroglu A, Poll A, Lepage P, Wong N, Nederlof PM, Ashworth A, Tonin PN, Narod SA, Livingston DM, Foulkes WD. Tischkowitz M, et al. Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6788-93. doi: 10.1073/pnas.0701724104. Epub 2007 Apr 9. Proc Natl Acad Sci U S A. 2007. PMID: 17420451 Free PMC article.
14 results